Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating Erlotinib and Cetuximab with or without Bevacizumab in patients with metastatic or unresectable k…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages [Phase 2]
Phase 2 trial evaluating photodynamic therapy with HPPH for advanced non-small cell lung cancer causing airway obstruction was terminated, w…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC [Phase 1, Phase 2]
Phase I/II study of nab-paclitaxel and carboplatin with concurrent radiation therapy for unresectable stage III non-small cell lung cancer w…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated adjuvant cisplatin with either genomic-guided vinorelbine or pemetrexed in early-stage non-small cell lung cancer.…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in relapsed or refractory non-small cell lung cancer among non-smokers or former light smokers; trial ter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors [Phase 3]
Phase 3 clinical trial evaluating adjuvant erlotinib after surgical resection with or without chemotherapy in EGFR-positive non-small cell l…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) [Phase 1]
A Phase 1 clinical trial update for the V934/V935 cancer vaccine (V934-002) in selected solid tumors; the study is completed and results hav…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer [Phase 2]
An open-label Phase 2 trial comparing trametinib (GSK1120212) with docetaxel in stage IV KRAS-mutant non-small cell lung cancer. The study h…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine in combination with imatinib mesylate for recurrent or metastatic non-small cell lung cancer was termin…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial investigating chemotherapy with proton radiation for locally advanced non-small cell lung cancer; the study was terminated a…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial assessing pemetrexed/cisplatin as pre-operative treatment for early-stage nonsquamous non-small cell lung cancer. Completed wi…
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of Suberoylanilide Hydroxamic Acid in recurrent or advanced non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating IPI-504 in combination with docetaxel for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer [Phase 2]
This is a Phase 2 trial update on bevacizumab plus chemotherapy for EGFR-TKI–resistant non-squamous non-small cell lung cancer, focusing on …
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial assessing cisplatin, pemetrexed disodium, and radiation therapy followed by docetaxel in stage III non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer [Phase 2]
Phase 2 safety and efficacy trial comparing ipilimumab to pemetrexed in non-squamous non-small cell lung cancer was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial investigated temozolomide for stage IIIB/IV or recurrent non-small cell lung cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating cetuximab as maintenance therapy after platinum-based first-line chemotherapy for non-small cell lung cancer has co…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Phase I/II Calcitriol in Lung Cancer [Phase 1, Phase 2]
A Phase I/II trial of calcitriol in non-small cell lung cancer was terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 neoadjuvant trial in non-small cell lung cancer has completed, reporting on immune responses observed during treatment.
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating Erlotinib hydrochloride with or without carboplatin and paclitaxel in stage III-IV non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
This clinical trial update reviews diagnosis and treatment strategies for patients with stage IIIB/IV non-small cell lung cancer, including …
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Usefulness of Blood Biomarkers for Overall Survival in NSCLC
The study evaluates whether blood-based biomarkers can predict overall survival in non-small cell lung cancer. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524
The clinical trial MCCRC-RC0524 evaluating pemetrexed disodium in stage III/IV non-small cell lung cancer reports tumor responses observed i…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating stereotactic body radiation therapy for inoperable stage I or II non-small cell lung cancer.